Home » Stocks » GENE

Genetic Technologies Ltd. (GENE)

Stock Price: $3.60 USD 0.02 (0.56%)
Updated May 13, 2021 4:00 PM EDT - Market closed
After-hours: $3.75 +0.15 (4.17%) May 13, 7:50 PM
Market Cap 56.85M
Revenue (ttm) 6,803
Net Income (ttm) -4.21M
Shares Out 15.03M
EPS (ttm) -0.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $3.60
Previous Close $3.58
Change ($) 0.02
Change (%) 0.56%
Day's Open 3.56
Day's Range 3.54 - 3.70
Day's Volume 175,928
52-Week Range 1.87 - 10.30

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

MELBOURNE, Australia, May 13, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business, today a...

14 hours ago - GlobeNewsWire

MELBOURNE, Australia, April 12, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), announces the appointment of Michael Tonroe to th...

1 month ago - GlobeNewsWire

MELBOURNE, Australia, April 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business provid...

1 month ago - GlobeNewsWire

MELBOURNE, Australia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announc...

2 months ago - GlobeNewsWire

Genetic Technologies Limited (GENE) Acting CEO George Muchnicki on Quarterly Investor Webinar Transcript

3 months ago - Seeking Alpha

MELBOURNE, Australia, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announc...

3 months ago - GlobeNewsWire

Genetic Technologies (NASDAQ: GENE) shares are trading higher after the company provided an update on its COVID-19 severity risk test, saying predictive capabilities improved 100% over age and sex alone...

Other stocks mentioned: OBLN, ADXN
3 months ago - Benzinga

MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announc...

3 months ago - GlobeNewsWire

Shares of GENE stock are rising on Thursday morning after Genetic Technologies provided a positive update regarding two important initatives. The post GENE Stock Alert: 10 Things to Know About Genetic T...

3 months ago - InvestorPlace

MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on fur...

3 months ago - GlobeNewsWire

MELBOURNE, Australia, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce an interview with its interi...

5 months ago - GlobeNewsWire

MELBOURNE, Australia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce its interim-CEO, Dr. Jerzy M...

5 months ago - GlobeNewsWire

MELBOURNE, Australia, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on the dev...

7 months ago - GlobeNewsWire

MELBOURNE, Australia, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG, NASDAQ:GENE) (“Genetic Technologies” or the "Company") is developing a Po...

7 months ago - GlobeNewsWire

MELBOURNE, Australia, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, “Company”) is delighted to announce that initial sales of its G...

8 months ago - GlobeNewsWire

MELBOURNE, Australia, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, is pleased...

8 months ago - GlobeNewsWire

MELBOURNE, Australia, July 20, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today annou...

9 months ago - GlobeNewsWire

Vaccine hopes and some upbeat banking earnings have boosted the risk-on sentiments in Wall Street.

Other stocks mentioned: JETS, KRE, MORT, PEJ, PSCH, RCL
9 months ago - Zacks Investment Research

MELBOURNE, Australia, July 16, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today annou...

9 months ago - GlobeNewsWire

MELBOURNE, Australia, June 23, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”) is pleased to announce that its interim-CEO ...

10 months ago - GlobeNewsWire

MELBOURNE, Australia, May 28, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announ...

11 months ago - GlobeNewsWire

MELBOURNE, Australia, May 26, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announ...

11 months ago - GlobeNewsWire

MELBOURNE, Australia, May 22, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”) provides the following operational updates:

11 months ago - GlobeNewsWire

MELBOURNE, Australia, May 20, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is to commence accelerating development of a polygenic risk score (PRS) test to predict an ...

11 months ago - GlobeNewsWire

Temporary transition to high throughput COVID-19 testing Temporary transition to high throughput COVID-19 testing

1 year ago - GlobeNewsWire

MELBOURNE, Australia, April 06, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today anno...

1 year ago - GlobeNewsWire

Genetic Tech (GENE) news for Wednesday includes GENE stock falling after the release of consumer tests for breast and colorectal cancer.

1 year ago - InvestorPlace

MELBOURNE, Australia, April 01, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today anno...

1 year ago - GlobeNewsWire

MELBOURNE, Australia, April 01, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market.

1 year ago - GlobeNewsWire

MELBOURNE, Australia, March 13, 2020 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a  leader in the development of genetic risk assessment tests, today ann...

1 year ago - GlobeNewsWire

MELBOURNE, Australia, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE) is pleased to advise that its third-generation breast cancer...

1 year ago - GlobeNewsWire

MELBOURNE, Australia, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce the full commissioning of its Australian Laboratory for ...

1 year ago - GlobeNewsWire

MELBOURNE, Australia, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company, announced today an update to shar...

1 year ago - GlobeNewsWire

Genetic Technologies Limited (NYSE: GENE), a provider of world-leading genetic risk assessment test products today announced that it has signed a 3-year Collaboration Agreement with TGen.

1 year ago - Benzinga

About GENE

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the comp... [Read more...]

Industry
Diagnostics & Research
Founded
1989
Stock Exchange
NASDAQ
Ticker Symbol
GENE
Full Company Profile

Financial Performance

In 2020, GENE's revenue was 9,864, a decrease of -61.23% compared to the previous year's 25,444. Losses were -6.10 million, -5.08% less than in 2019.

Financial numbers in millions AUD.
Financial Statements